clinical trial diversity

R&D

Implications of regulatory and FDA guidance on diversity, eq...

It is well established that focusing on diversity in clinical trials is essential for developing therapies that are safe and effective for different patient populations.

R&D

Clinical trial disparities and how to build a more inclusive...

Historically, clinical trials have lacked diversity amongst both study participants and researchers.

R&D

Strong solutions for increasing dermatology research diversi...

As a woman of colour, I am very careful about the skin care products I use. I must be.

Patients

Clinical trial diversity: An update

Editor-in-chief Jonah Comstock welcomes back returning guest Dr Jennifer Jones-McMeans, divisional vice president for global affairs for Abbott’s vascular business.

R&D